Nilotinib included in the Medicines Patent Pool; New voluntary licensing agreement between the Medicines Patent Pool (MPP) and Novartis
The Medicines Patent Pool (MPP) and Novartis have unveiled a new voluntary licensing agreement to allow generic drugmakers in seven middle i...
Frantzeska Papadopoulou -
Thursday, October 27, 2022
Nilotinib included in the Medicines Patent Pool; New voluntary licensing agreement between the Medicines Patent Pool (MPP) and Novartis
Reviewed by Frantzeska Papadopoulou
on
Thursday, October 27, 2022
Rating:
Reviewed by Frantzeska Papadopoulou
on
Thursday, October 27, 2022
Rating: